TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/11/18 18:02 | 6/8/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | CT | D | S.d | -1,795 | 179.55 | 0 | -10 | -100 | 0 | D | |||||||||||||||
12/22/17 16:14 | 12/20/17 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | CT | D | S | -805 | 80.49 | 0 | -10 | -100 | 0 | D | |||||||||||||||
11/27/17 16:56 | 11/22/17 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | CT | D | S.d | -228 | 75.85 | 0 | -3 | -23 | 10 | D | |||||||||||||||
8/28/03 20:07 | 8/26/03 | ESPR | Esperion Therapeutics Inc/mi | DE | Health | Drug | Pharmaceutical Preparations | Mayleben Timothy M | MI | O | COO,CFO | S | -424 | 16.00 | 0 | -27 | -35 | 50 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |